This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
KHAN MAB., HASHIM MJ., KING JK., GOVENDER RD., MUSTAFA HM., KAABI JA. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. Journal of Epidemiology and Global Health. 2020;10(1):107–111.Search in Google Scholar
PAPATHEODOROU K., BANACH M., BEKIARI E., RIZZO M., EDMONS M. Complications of diabetes 2017. Journal of Diabetes Research. Volume 2018. Article ID 3086167.Search in Google Scholar
SHI GJ., SHI GR., ZHOU JY., ZHANG WJ., GAO CY., JIANG YP., et al. Involvement of growth factors in diabetes mellitus and its complications: a general review. Biomedicine & Pharmacotheraphy. 2018;101:510–527.Search in Google Scholar
MAJUMDER S., ADVANI A. VEGF and the diabetic kidney: more than too much a good thing. Journal of Diabetes and Its Complications. 2017;31:273–279.Search in Google Scholar
HOFER KB. Vascular endothelial growth factor, from basic research to clinical applications. Int J Mol Sci. 2018. 19. 3750.Search in Google Scholar
SUN X., ZHANG H., LIU J. WANG G. Serum vascular endothelial growth factor level is elevated in patients with impaired glucose tolerance and type 2 diabetes mellitus. Journal of International Medical Research. 2019;47(11):5584–5592.Search in Google Scholar
TAHERGORABI Z., KHAZAEI M. Imbalance of angiogenesis in diabetic complications: the mechanism. Int J Prev Med. 2012;3:827–38.Search in Google Scholar
MAHDY RA., NADA WM., HADHOUD KM., EL-TARHONY SA. The role of vascular endothelial growth factor in the progression of diabetic vascular complications. Eye. 2010;24:1576–1584.Search in Google Scholar
AHUJA S., SAXENA S., AKDUMAN L., MEYER CH., KRUZLIAK P., KHANNA VK. Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy. Int J Retin Vitr. 2019.5:25.Search in Google Scholar
AMERICAN DIABETES ASSOCIATION. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–SC28.Search in Google Scholar
CHENG R., MA JX. Angiogenesis in diabetes and obesity. Rev Endocr Metab Disord. 2015;16(1):67–75.Search in Google Scholar
SUNG HK., DOH KO., SON JE., PARK JG., BAE Y., CHOI S., et al. Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metabolism. 2013;17:61–72.Search in Google Scholar
LOEBIG M., KLEMENT J., SCHMOLLER A., BETZ S., HEUCK N., SCHWEIGER U., et al. Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men. PLoS ONE. 2010;5(9):e12610.Search in Google Scholar
ZHANG Q., FANG W., MA L., WANG ZD., YANG YM., LU YQ. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes. Medicine. 2018;97:15(e0415).Search in Google Scholar
RUSDIANA R., WIDJAYA SS., AMELIA R., SYARIFAH S., RUSMALAWATI R. The role vascular endothelial growth factor, control glycemic, lipid profile, and hypoxiainducible factor-1alpha at type 2 diabetic patients in North Sumatera, Indonesia. Open Access Maced J Med Sci. 2021;9(B):1215–1218.Search in Google Scholar
TUFRO A., VERON D. VEGF and podocytes in diabetic nephropathy. Semin Nephrol. 2012;32(4):385–393.Search in Google Scholar
ZORENA K., MYSLIWSKA J., MYSLIWIEC M. KAPTURSKA KR., MALINOWSKA E., WISNIEWSKI P., et al. Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus. Journal of Human Hypertension. 2010;24:755–762.Search in Google Scholar
JIA G., SOWERS JR. Hypertension in diabetes: an update of basic mechanisms and clinical disease. Hypertension. 2021;78:1197–1205.Search in Google Scholar
MONDAL LK., PRAMANIK S., CHOWDHURY S., BOSE C., BERA D., SAHA A., et al. Do different lipid components accelerate the pathogenesis and severity of diabetic retinopathy.? International Journal of Retina and Vitreous. 2022;8:39.Search in Google Scholar
ZHANG X., QIU B., WANG Q., SIVAPRASAD S., WANG Y., ZHAO L., et al. Dysregulated serum lipid metabolism promotes the occurrence and development of diabetic retinopathy associated with upregulated circulating levels of VEGF-A, VEGF-D, and PIGF. Front. Med. 2021.8:779413.Search in Google Scholar
